DarioHealth Corp. (DRIO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 9.58M USD | Liabilities, Current |
| Cash and equivalents | 6.63M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.72M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $9.58M | $6.63M | (m) | (m) | $3.72M | (m) |
| 2026-03-31 | (m) | $9.36M | $14.98M | (m) | (m) | $4.17M | (m) |
| 2025-12-31 | (m) | $9.32M | $21.80M | (m) | (m) | $4.32M | (m) |
| 2025-09-30 | (m) | $9.28M | $31.91M | (m) | (m) | $4.87M | (m) |
| 2025-06-30 | (m) | $9.75M | $21.95M | (m) | (m) | $4.61M | (m) |
| 2025-03-31 | (m) | $19.16M | $27.85M | (m) | (m) | $4.62M | (m) |
| 2024-12-31 | (m) | $16.64M | $27.76M | (m) | (m) | $4.75M | (m) |
| 2024-09-30 | (m) | $18.85M | $15.55M | (m) | (m) | $4.74M | (m) |
| 2024-06-30 | (m) | $17.42M | $22.94M | (m) | (m) | $5.13M | (m) |
| 2024-03-31 | (m) | $17.80M | $34.37M | (m) | (m) | $4.92M | (m) |
| 2023-12-31 | (m) | $12.49M | $36.80M | (m) | (m) | $5.06M | (m) |
| 2023-09-30 | (m) | $8.11M | $43.88M | (m) | (m) | $5.47M | (m) |
| 2023-06-30 | (m) | $8.08M | $52.60M | (m) | (m) | $5.91M | (m) |
| 2023-03-31 | (m) | $17.62M | $38.79M | (m) | (m) | $6.88M | (m) |
| 2022-12-31 | (m) | $19.35M | $49.36M | (m) | (m) | $7.96M | (m) |
| 2022-09-30 | (m) | $11.52M | $57.08M | (m) | (m) | $7.76M | (m) |
| 2022-06-30 | (m) | $12.99M | $67.95M | (m) | (m) | $8.35M | (m) |
| 2022-03-31 | (m) | $13.10M | $55.56M | (m) | (m) | $7.78M | (m) |
| 2021-12-31 | (m) | $14.38M | $35.81M | (m) | (m) | $6.23M | (m) |
| 2021-09-30 | (m) | $12.68M | $51.33M | (m) | (m) | $4.06M | (m) |
| 2021-06-30 | (m) | $12.74M | $63.87M | (m) | (m) | $4.58M | (m) |
| 2021-03-31 | (m) | $11.74M | $81.17M | (m) | (m) | $5.02M | (m) |
| 2020-12-31 | (m) | $7.03M | $28.59M | (m) | (m) | $2.29M | (m) |
| 2020-09-30 | (m) | $5.85M | $36.91M | (m) | (m) | $1.57M | (m) |
| 2020-06-30 | (m) | $4.66M | $13.18M | (m) | (m) | $1.34M | (m) |
| 2020-03-31 | (m) | $4.23M | $15.83M | (m) | (m) | $1.22M | (m) |
| 2019-12-31 | (m) | $5.22M | $20.39M | (m) | (m) | $1.41M | (m) |
| 2019-09-30 | (m) | $4.22M | $4.58M | (m) | (m) | $1.47M | (m) |
| 2019-06-30 | (m) | $5.72M | $7.99M | (m) | (m) | $1.82M | (m) |
| 2019-03-31 | (m) | $7.02M | $6.96M | (m) | (m) | $1.92M | (m) |
| 2018-12-31 | (m) | $5.16M | $11.00M | (m) | (m) | $1.38M | (m) |
| 2018-09-30 | (m) | $3.92M | $11.43M | (m) | (m) | $1.02M | (m) |
| 2018-06-30 | (m) | $3.94M | $5.01M | (m) | (m) | $1.17M | (m) |
| 2018-03-31 | (m) | $2.41M | $7.04M | (m) | (m) | $912.00K | (m) |
| 2017-12-31 | (m) | $3.02M | $3.72M | (m) | (m) | $1.18M | (m) |
| 2017-09-30 | (m) | $3.34M | $6.26M | (m) | (m) | $924.00K | (m) |
| 2017-06-30 | (m) | $2.78M | $3.90M | (m) | (m) | $717.00K | (m) |
| 2017-03-31 | (m) | $2.72M | $2.82M | (m) | (m) | $849.00K | (m) |
| 2016-12-31 | (m) | $2.92M | $1.09M | (m) | $0.00 | $888.00K | (m) |
| 2016-09-30 | (m) | $2.04M | $3.34M | (m) | (m) | $1.12M | (m) |
| 2016-06-30 | (m) | $1.97M | $6.38M | (m) | (m) | $1.01M | (m) |
| 2016-03-31 | (m) | $1.49M | $8.27M | (m) | (m) | $1.00M | (m) |
| 2015-12-31 | (m) | $1.69M | $2.67M | (m) | $291.00K | $601.00K | (m) |
| 2015-09-30 | (m) | $1.53M | $1.91M | (m) | (m) | $315.00K | (m) |
| 2015-06-30 | (m) | $1.55M | $981.00K | (m) | (m) | $207.00K | (m) |
| 2015-03-31 | (m) | $1.67M | $1.85M | (m) | (m) | $231.00K | (m) |
| 2014-12-31 | (m) | $1.62M | $1.45M | (m) | $94.00K | $234.00K | (m) |
| 2014-09-30 | (m) | $2.09M | $4.17M | (m) | (m) | $109.00K | (m) |
| 2014-06-30 | (m) | $1.78M | $1.82M | (m) | (m) | $22.00K | (m) |
| 2014-03-31 | (m) | $1.22M | $3.81M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $1.51M | $2.26M | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $1.09M | $4.47M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $1.33M | $7.03M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $1.20M | $294.90K | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $566.75K | $1.23M | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | $820.02K | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $1.01M | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | $1.50M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $908.76K | (m) | (m) | (m) | (m) |
| 2011-08-10 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |